Gb Sciences (NASDAQ:GBLX) | WebDisclosure

Basculer en Français

8396	Companies
122097	Keywords
60577	Articles
65553	Press releases

Home
Companies
Gb Sciences

BRIEF

published on 10/15/2024 at 13:05, 2 months 6 days ago

GB Sciences Secures Licensing Deal with EndoPure Life Sciences

Clinical Trials GB Sciences Licensing Deal EndoPure Parkinson's Treatment
BRIEF

published on 10/15/2024 at 13:05, 2 months 6 days ago

GB Sciences conclut un accord de licence avec EndoPure Life Sciences

Essais Cliniques Accord De Licence EndoPure Sciences GB Traitement De La Maladie De Parkinson
PRESS RELEASE

published on 10/15/2024 at 13:00, 2 months 6 days ago

GB Sciences Signs Licensing Deal With EndoPure Life Sciences for 5% Gross Sales Royalty & Sponsorship of First-in-Human Trial for Their Cannabinoid-Based Parkinson’s Drug
EndoPure Life Sciences to finance first-in-human clinical trials for GB Sciences' cannabinoid-based products through exclusive licensing deal. Aging populations drive global demand for treatments of neurological disorders

Global Market Growth Neurological Disorders Endopure Life Sciences First-in-human Clinical Trials Cannabinoid-based Products
BRIEF

published on 07/02/2024 at 15:05, 5 months 19 days ago

GB Sciences Signs Licensing Deal with Endopure Life Sciences for Cannabinoid-Based Neurological Treatments

Neurological Disorders GB Sciences Endopure Life Sciences Cannabinoid-based Treatments Licensing Deal
BRIEF

published on 07/02/2024 at 15:05, 5 months 19 days ago

GB Sciences signe un accord de licence avec Endopure Life Sciences pour des traitements neurologiques à base de cannabinoïdes

Troubles Neurologiques Accord De Licence GB Sciences Sciences De La Vie Endopure Traitements À Base De Cannabinoïdes
PRESS RELEASE

published on 07/02/2024 at 15:00, 5 months 19 days ago

GB Sciences Signs Letter of Intent for a License to Develop and Market Their Cannabinoid-Based Parkinson’s Formulation With Endopure Life Sciences
GB Sciences partners with Endopure Life Sciences for licensing deal on cannabinoid-based treatments for neurological disorders in Brazil and South America, addressing growing market demand

Neurological Disorders GB Sciences Endopure Life Sciences Cannabinoid-based Treatments Licensing Deal
PRESS RELEASE

published on 12/14/2023 at 13:00, 1 year ago

Gb Sciences’ Novel Parkinson’s Disease Medication is Featured on Worldwide Business with kathy ireland(R)
PRESS RELEASE

published on 07/11/2023 at 13:00, 1 year 5 months ago

Gb Sciences' First-in-Class Parkinson's Disease Therapy Successfully Completes Dose Response Study at the University of Lethbridge
PRESS RELEASE

published on 03/20/2023 at 12:00, 1 year 9 months ago

GB Sciences' First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson's Disease Has Been Issued in China
PRESS RELEASE

published on 03/07/2023 at 15:00, 1 year 9 months ago

Successful 2022 Milestones Support Value of Gb Sciences' AI-Enabled Drug Discovery Platform

Accesswire

Published on 12/21/2024 at 01:30, 17 hours 52 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 17 hours 52 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 19 hours 17 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 19 hours 22 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 19 hours 52 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

EQS Group

Published on 12/21/2024 at 00:51, 18 hours 31 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 37 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 1 day ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 1 day ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

ARYZTA AG Announces New Board Technology Committee

Les Echos

Published on 12/21/2024 at 12:17, 7 hours 4 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 7 hours 4 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 1 hour ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE